Captrust Financial Advisors Citius Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.88 - $1.87 $6,240 - $13,260	-7,091 Reduced 73.93%	2,500 $2,000
Q1 2022 May 16, 2022	BUY	$1.38 - $1.89 $1,380 - $1,890	1,000 Added 11.64%	9,591 $17,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $7,577 - $11,039	5,018 Added 140.44%	8,591 $13,000
Q3 2021 Nov 16, 2021	SELL	$1.74 - $2.6 $2,933 - $4,383	-1,686 Reduced 32.06%	3,573 $7,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $4,166 - $11,670	2,759 Added 110.36%	5,259 $18,000
Q1 2021 May 17, 2021	BUY	$1.04 - $2.34 $2,600 - $5,850	2,500 New	2,500 $4,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $376M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.